analyst
AD
NYSE · ADCT
ADC Therapeutics S.A.
Healthcare · Biotechnology
$1.14
Up+$0.02 (+1.79%)
Updated Aug 29, 2026, 3:54 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 507.9M
- P/E ratio
- -3.35
- Dividend yield
- 0.00%
- 52-week range
- $0.78 – $4.98
- Volume
- 2.58M
- Avg. volume
- 1.16M
Price performance
ADCT price history
1M range · 21 trading sessions · Daily adjusted prices
ADCT closed at $1.14 after 21 trading sessions, up 8.57% for the selected period.
- Last close
- $1.14
- Period change
- +8.57%
- Period low
- $0.96
- Period high
- $1.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $1.11 | $1.17 | $1.07 | $1.14 | 2.58M |
| Aug 27, 2026 | $1.05 | $1.14 | $1.05 | $1.12 | 1.4M |
| Aug 26, 2026 | $1.04 | $1.075 | $1.01 | $1.05 | 1.95M |
| Aug 25, 2026 | $0.9755 | $1.05 | $0.96 | $1.04 | 3.93M |
| Aug 24, 2026 | $0.99 | $1.00 | $0.9514 | $0.9651 | 640.51K |
| Aug 21, 2026 | $0.974 | $1.00 | $0.97 | $0.9966 | 1.09M |
| Aug 20, 2026 | $1.02 | $1.04 | $0.9497 | $0.9601 | 2.42M |
| Aug 19, 2026 | $1.05 | $1.09 | $1.015 | $1.04 | 1.9M |
| Aug 18, 2026 | $1.05 | $1.08 | $1.03 | $1.03 | 3.44M |
| Aug 17, 2026 | $0.99 | $1.10 | $0.95 | $1.10 | 3.73M |
| Aug 14, 2026 | $1.02 | $1.04 | $1.00 | $1.01 | 1.35M |
| Aug 13, 2026 | $1.07 | $1.10 | $0.9393 | $1.05 | 2.19M |
| Aug 12, 2026 | $1.20 | $1.23 | $1.155 | $1.23 | 563.56K |
| Aug 11, 2026 | $1.11 | $1.20 | $1.11 | $1.18 | 664.34K |
| Aug 10, 2026 | $1.14 | $1.17 | $1.12 | $1.13 | 569.55K |
| Aug 7, 2026 | $1.08 | $1.17 | $1.08 | $1.13 | 534.56K |
| Aug 6, 2026 | $1.07 | $1.13 | $1.07 | $1.13 | 722.74K |
| Aug 5, 2026 | $1.11 | $1.15 | $1.07 | $1.07 | 971.14K |
| Aug 4, 2026 | $1.05 | $1.12 | $1.04 | $1.10 | 1.37M |
| Aug 3, 2026 | $1.07 | $1.08 | $1.03 | $1.05 | 866.39K |
| Jul 31, 2026 | $1.11 | $1.12 | $1.045 | $1.05 | 757.73K |
Latest ADCT news
The latest Smart Investors Daily articles mentioning ADCT.
Stock researchResearch & News · News
Loading stock research…

